CareLit Fachartikel
Long-term efficacy and safety of intravenous (IV) Tulisokibart in patients with crohn’s disease (CD): Results from the open-label extension period of the phase 2 APOLLO-CD study
M Sossdorf, C A Siegel, R W Leong, J K Anderson, M Yen, B Dong, B E Sands, S Danese, B G Feagan · Zeitschrift für Gastroenterologie · 2025 · Heft 08 · S. e425
Dokument
953744
CareLit-ID
Jahr
2025
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Long-term efficacy and safety of intravenous (IV) Tulisokibart in patients with crohn’s disease (CD): Results from the open-label extension period of the phase 2 APOLLO-CD study
Schlagworte
Long-Term
Efficacy
Safety
Intravenous
Tulisokibart
Patients
Crohn
Disease
Results
Open-Label
Extension
Period
Zeitschrift für Gastroenterologie
